The Management of Oligometastases in Non-small Cell Lung Cancer- is Stereotactic Ablative Radiotherapy now Standard of Care?

被引：4

作者：

Ratnakumaran, R. ^{[1
,2
]}

McDonald, F. ^{[1
,2
]}

机构：

[1] Royal Marsden NHS Fdn Trust, Lung Unit, London, England

[2] Inst Canc Res, Div Radiotherapy & Imaging, London, England

来源：

CLINICAL ONCOLOGY | 2022年 / 34卷 / 11期

关键词：

Non-small cell lung cancer; oligometastases; oligoprogression; stereotactic ablative radiotherapy; stereotactic body radiotherapy; BODY RADIATION-THERAPY; RESPONSE EVALUATION CRITERIA; 1ST-LINE SYSTEMIC THERAPY; CIRCULATING TUMOR DNA; PHASE I/II TRIAL; CHEMOTHERAPY; SURVIVAL; PEMBROLIZUMAB; METASTASIS; RESECTION;

D O I：

10.1016/j.clon.2022.08.033

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Oligometastatic non-small cell lung cancer encompasses a number of distinct clinical scenarios with a pattern of limited tumour burden on imaging. Delivering local ablative therapy to individual metastatic lesions may assist in disease modification and contribute to improved outcomes. We review the published randomised clinical trials that support the implementation of stereotactic ablative radiotherapy as a standard of care in certain oligometastatic non-small cell lung cancer clinical scenarios, and highlight the current knowledge gaps and areas of ongoing research.(c) 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

引用

页码：753 / 760

页数：8

共 51 条

[1] SURVIVAL DETERMINANTS IN EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER - THE SOUTHWEST-ONCOLOGY-GROUP EXPERIENCE [J].

ALBAIN, KS ;

CROWLEY, JJ ;

LEBLANC, M ;

LIVINGSTON, RB .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) :1618-1626

[2] Solitary colorectal liver metastasis - Resection determines outcome [J].

Aloia, TA ;

Vauthey, JN ;

Loyer, EM ;

Ribero, D ;

Pawlik, TM ;

Wei, SH ;

Curley, SA ;

Zorzi, D ;

Abdalla, EK .

ARCHIVES OF SURGERY, 2006, 141 (05) :460-466

[3] An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small-Cell Lung Cancer [J].

Ashworth, Allison B. ;

Senan, Suresh ;

Palma, David A. ;

Riquet, Marc ;

Ahn, Yong Chan ;

Ricardi, Umberto ;

Congedo, Maria T. ;

Gomez, Daniel R. ;

Wright, Gavin M. ;

Melloni, Giulio ;

Milano, Michael T. ;

Sole, Claudio V. ;

De Pas, Tommaso M. ;

Carter, Dennis L. ;

Warner, Andrew J. ;

Rodrigues, George B. .

CLINICAL LUNG CANCER, 2014, 15 (05) :346-355

[4]

Cancer Research UK, 2022, LUNG CANC STAT

[5]

Chalkidou A, 2021, LANCET ONCOL, V22, P98, DOI 10.1016/S1470-2045(20)30537-4

[6] Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management [J].

Correa, Rohann J. M. ;

Salama, Joseph K. ;

Milano, Michael T. ;

Palma, David A. .

CANCER JOURNAL, 2016, 22 (04) :247-256

[7] Surgical approach in the oligometastatic patient [J].

Divisi, Duilio ;

Barone, Mirko ;

Zaccagna, Gino ;

Gabriele, Francesca ;

Crisci, Roberto .

ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (05)

[8] Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials [J].

Drilon, Alexander ;

Siena, Salvatore ;

Dziadziuszko, Rafal ;

Barlesi, Fabrice ;

Krebs, Matthew G. ;

Shaw, Alice T. ;

de Braud, Filippo ;

Rolfo, Christian ;

Ahn, Myung-Ju ;

Wolf, Juergen ;

Seto, Takashi ;

Cho, Byoung Chul ;

Patel, Manish R. ;

Chiu, Chao-Hua ;

John, Thomas ;

Goto, Koichi ;

Karapetis, Christos S. ;

Arkenau, Hendrick-Tobias ;

Kim, Sang-We ;

Ohe, Yuichiro ;

Li, Yu-Chung ;

Chae, Young K. ;

Chung, Christine H. ;

Otterson, Gregory A. ;

Murakami, Haruyasu ;

Lin, Chia-Chi ;

Tan, Daniel S. W. ;

Prenen, Hans ;

Riehl, Todd ;

Chow-Maneval, Edna ;

Simmons, Brian ;

Cui, Na ;

Johnson, Ann ;

Eng, Susan ;

Wilson, Timothy R. ;

Doebele, Robert C. .

LANCET ONCOLOGY, 2020, 21 (02) :261-270

[9] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].

Eisenhauer, E. A. ;

Therasse, P. ;

Bogaerts, J. ;

Schwartz, L. H. ;

Sargent, D. ;

Ford, R. ;

Dancey, J. ;

Arbuck, S. ;

Gwyther, S. ;

Mooney, M. ;

Rubinstein, L. ;

Shankar, L. ;

Dodd, L. ;

Kaplan, R. ;

Lacombe, D. ;

Verweij, J. .

EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247

[10] Staging the Metastatic Spectrum Through Integration of Clinical and Molecular Features [J].

Foster, Corey C. ;

Pitroda, Sean P. ;

Weichselbaum, Ralph R. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15) :1270-+

← 1 2 3 4 5 6 →